Coreg combined with Vitamins

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Skin Laceration Other Serious 1/1/2001 55 Female 167 lb 1/5/2006 Consumer United States
Primary
Concomitant
Blood Urea Increased Hospitalization 1/1/2001 62 Male 1/31/2006 Consumer United States
Primary
Concomitant
Thrombocytopenia Other Serious 9/1/2005 78 Male 3/2/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 1/1/2005 Female 185 lb 3/21/2006 Consumer United States
Primary
Concomitant
Vomiting Required Intervention 2/7/2006 Female 210 lb 3/20/2006 Physician United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 2/4/2006 66 Female 126 lb 4/6/2006 United States
Primary
Secondary
Concomitant
Mood Swings 10/27/2005 82 Male 1/25/2006 Consumer United States
Primary
Concomitant
Thrombosis Other Serious 1/1/2006 74 Female 129 lb 4/20/2006 Physician United States
Primary
Concomitant
Urinary Retention 57 Female 4/28/2006 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 7/1/2005 57 Female 7/19/2006 Consumer United States
Primary
Concomitant
Rash Pruritic Other Serious 3/1/2005 75 Male 194 lb 8/1/2006 Consumer United States
Primary
Concomitant
Initial Insomnia 3/27/2006 54 Female 156 lb 7/12/2006 Consumer United States
Primary
Concomitant
Corneal Deposits Other Serious 7/31/2006 87 Female 8/4/2006 Consumer United States
Primary
Concomitant
Drug Ineffective 10/1/2005 82 Female 8/10/2006 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased Other Serious 1/1/2004 Male 146 lb 8/15/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Corneal Deposits Other Serious 7/31/2006 87 Female 9/1/2006 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased Other Serious 1/1/2004 Male 146 lb 9/7/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Rash Other Serious 7/1/2005 Male 9/26/2006 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 7/31/2006 87 Female 10/2/2006 Consumer United States
Primary
Concomitant
Ill-defined Disorder Other Serious 56 Male 182 lb 9/29/2006 United States
Primary
Secondary
Concomitant
Rash Other Serious 7/1/2005 Male 10/11/2006 Consumer United States
Primary
Concomitant
Rash Other Serious 7/1/2005 Male 10/17/2006 Consumer United States
Primary
Concomitant
Oedema Peripheral Hospitalization 8/1/2006 56 Male 134 lb 10/25/2006 Consumer United States
Primary
Concomitant
Loss Of Consciousness Other Serious 10/19/2006 84 Male 10/21/2006 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective Other Serious 1/1/2001 51 Male 11/9/2006 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred 90 Male 11/13/2006 Consumer United States
Primary
Concomitant
Visual Disturbance Male 11/13/2006 Consumer United States
Primary
Concomitant
Tinnitus 70 Female 11/13/2006 Consumer United States
Primary
Concomitant
Rash 10/27/2005 70 Female 11/13/2006 Consumer United States
Primary
Concomitant
Pruritus 1/1/2004 79 Female 11/13/2006 Consumer United States
Primary
Concomitant
Alopecia 76 Female 11/13/2006 Consumer United States
Primary
Concomitant
Sleep Apnoea Syndrome Male 11/13/2006 Consumer United States
Primary
Concomitant
Drug Ineffective 57 Male 11/13/2006 Consumer United States
Primary
Concomitant
Loss Of Consciousness Other Serious 10/19/2006 84 Male 11/30/2006 Consumer United States
Primary
Secondary
Concomitant
Therapeutic Response Decreased Other Serious 1/1/2004 Male 146 lb 12/19/2006 Other Health Professional United States
Primary
Secondary
Concomitant
Drug Ineffective Male 12/28/2006 Consumer United States
Primary
Concomitant
Liver Function Test Abnormal Hospitalization 9/1/2006 80 Male 12/28/2006 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased Other Serious 1/1/2004 Male 146 lb 1/4/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Pharyngolaryngeal Pain Other Serious 2/28/2006 63 Female 130 lb 6/2/2006 Physician United States
Primary
Concomitant
Platelet Count Decreased Other Serious 73 Male 220 lb 2/23/2006 United States
Primary
Concomitant
Myocardial Infarction Death 77 Male 3/5/2007 Consumer United States
Primary
Concomitant
Loss Of Consciousness Other Serious 10/19/2006 84 Male 10/31/2006 Consumer United States
Primary
Secondary
Concomitant
Thinking Abnormal Other Serious 2/28/2007 60 Male 4/20/2007 United States
Primary
Secondary
Concomitant
Prostatic Specific Antigen Increased Other Serious Male 172 lb 4/25/2007 Physician United States
Primary
Concomitant
Loss Of Consciousness Other Serious 10/19/2006 84 Male 5/9/2007 Consumer United States
Primary
Secondary
Concomitant
Myocardial Infarction Hospitalization 8/16/2007 76 Female 9/10/2007 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2007 88 Female 10/3/2007 Consumer United States
Primary
Secondary
Concomitant
Therapeutic Response Unexpected Other Serious 5/10/2007 65 Male 10/10/2007 United States
Primary
Concomitant
Shock Other Serious 3/1/2005 Female 10/25/2007 Consumer United States
Primary
Concomitant
Migraine 60 Female 11/13/2007 Consumer United States
Primary
Concomitant
Rash 4/24/2007 59 Female 11/13/2007 Consumer United States
Primary
Concomitant
Palpitations 54 Male 11/13/2007 Consumer United States
Primary
Concomitant
Visual Disturbance 10/1/2006 68 Female 131 lb 11/13/2007 Consumer United States
Primary
Concomitant
Vision Blurred 67 Male 11/13/2007 Consumer United States
Primary
Concomitant
Dyspnoea 72 Female 11/13/2007 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2007 88 Female 11/13/2007 Consumer United States
Primary
Secondary
Concomitant
Rash 10/27/2005 70 Female 11/13/2007 Consumer United States
Primary
Concomitant
Oedema Female 11/13/2007 Other Health Professional United States
Primary
Concomitant
Weight Increased 6/15/2006 55 Male 243 lb 11/13/2007 Consumer United States
Primary
Concomitant
Weight Decreased 71 Male 166 lb 11/13/2007 Consumer United States
Primary
Concomitant
Speech Disorder 85 Male 11/13/2007 Consumer United States
Primary
Concomitant
Visual Disturbance 12/7/2006 68 Female 11/13/2007 Consumer United States
Primary
Secondary
Concomitant
Pharyngolaryngeal Pain 12/16/2006 48 Female 11/13/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Heart Rate Decreased 90 Male 11/14/2007 Consumer United States
Primary
Concomitant
Dyspnoea 84 Male 11/14/2007 Consumer United States
Primary
Concomitant
Myalgia 11/1/2006 69 Male 11/14/2007 Consumer United States
Primary
Concomitant
Fatigue 12/1/2006 Male 11/14/2007 Consumer United States
Primary
Concomitant
Fatigue Hospitalization 12/1/2006 75 Male 11/14/2007 Consumer United States
Primary
Concomitant
Overdose 82 Female 11/14/2007 Consumer United States
Primary
Concomitant
Irritability 1/1/2007 59 Male 230 lb 11/14/2007 Consumer United States
Primary
Concomitant
Weight Increased 63 Female 11/14/2007 Consumer United States
Primary
Concomitant
Weight Increased 9/1/2006 39 Male 11/14/2007 Consumer United States
Primary
Secondary
Concomitant
Therapeutic Response Decreased 1/1/2006 Female 12/20/2007 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased 1/1/2006 Female 1/23/2008 Consumer United States
Primary
Concomitant
Myocardial Infarction Hospitalization 8/16/2007 76 Female 2/7/2008 Consumer United States
Primary
Concomitant
Increased Upper Airway Secretion 9/1/2007 Female 4/10/2008 Consumer United States
Primary
Concomitant
Shock Other Serious 3/1/2005 Female 4/23/2008 Consumer United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2007 88 Female 6/16/2008 Consumer United States
Primary
Secondary
Concomitant
Dizziness 79 Female 135 lb 6/23/2008 Consumer United States
Primary
Concomitant
Nausea 5/1/2008 71 Male 223 lb 7/7/2008 Consumer United States
Primary
Concomitant
Sciatica Other Serious 1/1/2007 59 Female 10/14/2008 Consumer United States
Primary
Concomitant
Throat Tightness Hospitalization 4/30/2007 79 Female 207 lb 10/10/2008 United States
Primary
Concomitant
Renal Cancer Other Serious 1/1/2005 66 Male 11/4/2008 Other Health Professional United States
Primary
Concomitant
Dyspnoea 10/27/2007 67 Female 173 lb 11/13/2008 Consumer United States
Primary
Secondary
Concomitant
Pain In Extremity 7/1/2007 81 Male 11/13/2008 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 79 Female 11/13/2008 Consumer United States
Primary
Concomitant
Nipple Pain 1/1/2008 Male 12/5/2008 Consumer
Primary
Concomitant
Influenza 2/1/2008 Female 12/16/2008 Consumer United States
Primary
Concomitant
Weight Increased 77 Female 138 lb 12/17/2008 Consumer United States
Primary
Concomitant
Urine Flow Decreased 73 Male 12/10/2008 Consumer United States
Primary
Concomitant
Ventricular Arrhythmia Hospitalization 45 Male 199 lb 1/21/2009 Lawyer United States
Primary
Concomitant
Left Ventricular Dysfunction Hospitalization 45 Male 199 lb 1/24/2009 United States
Primary
Concomitant
Somnolence Other Serious 6/10/2008 Male 198 lb 2/4/2009 Consumer United States
Primary
Concomitant
Ventricular Arrhythmia Hospitalization 45 Male 199 lb 2/4/2009 Lawyer United States
Primary
Concomitant
Macular Degeneration Other Serious Male 204 lb 3/10/2009 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 2/1/2009 Female 154 lb 3/13/2009 Consumer United States
Primary
Concomitant
Platelet Count Decreased Other Serious Male 178 lb 3/14/2009 Consumer United States
Primary
Concomitant
Paralysis Other Serious 8/1/2008 38 Female 3/20/2009 United States
Primary
Concomitant
Skin Ulcer Other Serious 1/1/2005 62 Male 4/1/2009 Lawyer United States
Primary
Secondary
Concomitant
Somnolence Other Serious 6/10/2008 Male 198 lb 4/1/2009 Consumer United States
Primary
Concomitant
Skin Ulcer Other Serious 1/1/2005 62 Male 4/3/2009 Lawyer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2/1/2009 Female 154 lb 4/14/2009 Consumer United States
Primary
Concomitant
Pain Hospitalization 11/1/2007 60 Male 266 lb 4/20/2009 Consumer United States
Primary
Concomitant
Platelet Count Decreased Other Serious 6/1/2004 Male 178 lb 4/22/2009 Consumer United States
Primary
Concomitant
Cardiomyopathy Other Serious 4/5/2009 79 Male 5/1/2009 Consumer United States
Primary
Secondary
Concomitant
Paralysis Other Serious 8/1/2008 38 Female 5/4/2009 United States
Primary
Concomitant
Vision Blurred 71 Female 5/4/2009 Consumer United States
Primary
Secondary
Concomitant
Cardiomyopathy Other Serious 4/5/2009 79 Male 5/15/2009 Consumer United States
Primary
Secondary
Concomitant
Condition Aggravated Hospitalization 1/1/2009 51 Female 176 lb 5/28/2009 Other Health Professional United States
Primary
Concomitant
Platelet Count Decreased Other Serious 6/1/2004 Male 178 lb 6/5/2009 Other Health Professional United States
Primary
Secondary
Concomitant
Eructation 5/1/2009 Female 6/8/2009 Consumer
Primary
Concomitant
Therapeutic Response Decreased 10/1/2008 84 Female 7/23/2009 Other Health Professional United States
Primary
Concomitant
Visual Impairment 84 Male 8/10/2009 Consumer United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 70 Female 9/8/2009 United States
Primary
Concomitant
Ventricular Tachycardia Hospitalization 9/21/1998 66 Female 190 lb 9/18/2009 United States
Primary
Concomitant
Pollakiuria 82 Female 177 lb 10/12/2009 Consumer United States
Primary
Concomitant
Insomnia 1/1/2008 63 Female 11/13/2009 Consumer United States
Primary
Secondary
Concomitant
Heart Rate Decreased 5/1/2009 74 Male 11/18/2009 Consumer United States
Primary
Secondary
Concomitant
Ventricular Tachycardia Hospitalization 9/21/1998 66 Female 190 lb 11/17/2009 United States
Primary
Concomitant
Wrong Technique In Drug Usage Process 85 Female 12/22/2009 Consumer United States
Primary
Secondary
Concomitant
Muscle Spasms 12/1/2009 Female 120 lb 2/10/2010 Physician United States
Primary
Concomitant
Weight Decreased Other Serious 11/1/2008 Female 2/11/2010 Consumer United States
Primary
Secondary
Concomitant
Vision Blurred 71 Female 2/16/2010 Consumer United States
Primary
Secondary
Concomitant
Hepatic Cirrhosis Other Serious 2/22/2010 Male 3/1/2010 Consumer
Primary
Concomitant
Pyrexia Hospitalization 56 Female 3/18/2010 United States
Primary
Concomitant
Thrombosis Other Serious 9/1/2009 Male 3/23/2010 Consumer United States
Primary
Concomitant
Hepatic Cirrhosis Other Serious 2/22/2010 68 Male 4/9/2010 Consumer
Primary
Concomitant
Tenderness Other Serious Female 4/27/2010 United States
Primary
Concomitant
Coronary Artery Bypass Other Serious 1/1/2000 Female 5/13/2010 Consumer United States
Primary
Secondary
Concomitant
Nausea Other Serious 5/1/2010 81 Male 170 lb 6/4/2010 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2009 81 Male 223 lb 6/30/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 9/4/2009 87 Male 157 lb 7/7/2010 Consumer United States
Primary
Concomitant
Insomnia 1/1/2006 56 Male 210 lb 7/8/2010 Consumer United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2007 55 Female 165 lb 7/9/2010 Consumer United States
Primary
Concomitant
Weight Decreased 7/1/2007 90 Female 93 lb 7/14/2010 Other Health Professional United States
Primary
Concomitant
Nightmare 7/1/2007 62 Male 170 lb 7/14/2010 Consumer United States
Primary
Concomitant
Headache 8/1/2007 63 Male 185 lb 7/15/2010 Consumer United States
Primary
Concomitant
Drug Ineffective Other Serious 1/1/2004 51 Male 7/17/2010 Consumer United States
Primary
Secondary
Concomitant
Completed Suicide Death 10/1/2007 63 Male 177 lb 7/23/2010 Other Health Professional United States
Primary
Concomitant
Oropharyngeal Discomfort 1/14/2005 58 Female 122 lb 7/30/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Oedema Peripheral 68 Female 7/31/2010 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective 1/1/2006 70 Male 225 lb 8/2/2010 Other Health Professional United States
Primary
Concomitant
Completed Suicide Death 10/1/2007 64 Male 177 lb 5/18/2010 Other Health Professional United States
Primary
Concomitant
Troponin Increased Hospitalization 7/22/2010 61 Male 240 lb 8/30/2010 Physician United States
Primary
Secondary
Concomitant
Drug Ineffective 3/1/2009 77 Male 9/9/2010 Consumer United States
Primary
Concomitant
Paraesthesia Other Serious 2/1/2009 72 Female 9/13/2010 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 11/1/2008 61 Female 9/16/2010 Consumer United States
Primary
Secondary
Concomitant
Therapy Regimen Changed Other Serious 6/1/2010 67 Male 188 lb 9/17/2010 Consumer United States
Primary
Concomitant
Paraesthesia Other Serious 2/1/2009 72 Female 9/22/2010 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 4/1/2008 46 Female 159 lb 10/4/2010 Lawyer United States
Primary
Concomitant

Drug Data